Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00393848 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery

A Phase 2 study of Osteoarthritis and Hip Fracture, sponsored by University of Arkansas.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT00393848 is a Phase 2 study of Osteoarthritis and Hip Fracture that has completed, run by University of Arkansas. The registered enrollment target is 40 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00393848, a Phase 2 study of Osteoarthritis and Hip Fracture, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of two postoperative interventions designed to preserve muscle protein after major hip or knee surgery.

Interventions

  • DRUG Placebo
  • DRUG Ketoconazole
  • DRUG Essential amino acid supplement

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-10
Est. Completion 2012-10
Phase Phase 2

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT00393848

The ClinicalTrials.gov registry entry for NCT00393848 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00393848 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT00393848 about?

NCT00393848 is a clinical study titled "Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery". The purpose of this study is to determine the effects of two postoperative interventions designed to preserve muscle protein after major hip or knee surgery.

What is the current status of trial NCT00393848?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2006-10. Estimated completion is 2012-10.

What conditions does trial NCT00393848 study?

This clinical trial studies the following conditions: Osteoarthritis, Hip Fracture, Femur Head Necrosis.

What interventions are being tested in trial NCT00393848?

The interventions under investigation include: Placebo (DRUG), Ketoconazole (DRUG), Essential amino acid supplement (DRUG).

Who is sponsoring clinical trial NCT00393848?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00393848 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.